×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PALI – palisade bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PALI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
08:20 am
pali
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) [Yahoo! Finance]
Medium
Report
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) [Yahoo! Finance]
11/21
08:15 am
pali
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC)
Low
Report
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC)
11/20
05:40 pm
pali
Palisade Bio, Inc. (NASDAQ: PALI) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $38.00 price target on the stock.
Medium
Report
Palisade Bio, Inc. (NASDAQ: PALI) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $38.00 price target on the stock.
11/14
09:08 am
pali
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit [Yahoo! Finance]
High
Report
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit [Yahoo! Finance]
11/14
09:00 am
pali
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit
High
Report
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit
11/13
11:38 am
pali
Palisade Bio, Inc. (NASDAQ: PALI) had its price target lowered by analysts at Maxim Group from $22.50 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Palisade Bio, Inc. (NASDAQ: PALI) had its price target lowered by analysts at Maxim Group from $22.50 to $8.00. They now have a "buy" rating on the stock.
11/12
08:52 am
pali
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 [Yahoo! Finance]
Medium
Report
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 [Yahoo! Finance]
11/12
08:45 am
pali
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
Medium
Report
Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/22
05:13 pm
pali
Form FWP PALISADE BIO, INC. Filed by: PALISADE BIO, INC.
Medium
Report
Form FWP PALISADE BIO, INC. Filed by: PALISADE BIO, INC.
11/22
04:00 pm
pali
Form 4 PALISADE BIO, INC. For: Nov 21 Filed by: Williams Donald Allen
Medium
Report
Form 4 PALISADE BIO, INC. For: Nov 21 Filed by: Williams Donald Allen
11/22
04:00 pm
pali
Form 4 PALISADE BIO, INC. For: Nov 21 Filed by: Wei Binxian
Medium
Report
Form 4 PALISADE BIO, INC. For: Nov 21 Filed by: Wei Binxian
11/21
02:19 pm
pali
Form S-1/A PALISADE BIO, INC.
Medium
Report
Form S-1/A PALISADE BIO, INC.
11/14
03:35 pm
pali
Form SC 13G PALISADE BIO, INC. Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G PALISADE BIO, INC. Filed by: ARMISTICE CAPITAL, LLC
11/12
09:37 am
pali
Form 10-Q PALISADE BIO, INC. For: Sep 30
Medium
Report
Form 10-Q PALISADE BIO, INC. For: Sep 30
9/27
04:31 pm
pali
Form 8-K PALISADE BIO, INC. For: Sep 27
Medium
Report
Form 8-K PALISADE BIO, INC. For: Sep 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: